GlycoDesign Inc. acquired by Inflazyme
|
|
|
|
Ste. 400. 480 University Ave. Toronto CANON M5G 1V2 Canada |
| |
|
|
+1-416-5936027 |
|
|
+1-416-5938988 |
|
|
|
|
|
|
|
|
|
Development of novel therapeutics for treatment of cancer; infectious diseases and inflammation | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|